EVALI and vitamin E acetate — the facts

TL;DR

• EVALI = E-cigarette or Vaping product use Associated Lung Injury.
• US outbreak 2019: 2 807 cases, 68 deaths (CDC).
• Cause: vitamin E acetate as diluent in black-market THC oil.
• Blount 2020 (NEJM): vitamin E acetate found in 48/51 bronchoalveolar lavages.

How to protect yourself

• No cartridges from unknown sources — especially no street sales.
• Check the ingredient list: PG, VG, MCT, vitamin E, terpene diluents = caution.
• Dry-herb vaping with clean flower carries no EVALI risk.
• Symptoms (cough, shortness of breath, fever, chest pain) — seek medical care immediately.

EVALI: what actually happened in 2019

The EVALI wave in the USA (E-cigarette or Vaping product use-Associated Lung Injury) led to over 2,800 hospitalisations and 68 documented deaths. The US health authority CDC identified vitamin E acetate as the prime suspect: the substance was used as a cheap diluent in illicitly traded THC cartridges and was found in almost all analyzed lung lavage samples of those affected. Vitamin E acetate is harmless as a skincare ingredient, but when inhaled, it deposits in the lungs and disrupts the surfactant film.

The crucial point for classification: EVALI was not a problem of vaping as a method, but a problem of unregulated black-market formulations. Following the ban on the additive and public awareness campaigns, case numbers plummeted. Legal, declared, and laboratory-tested products were practically unaffected.

• Exclude vitamin E acetate (tocopheryl acetate) as an ingredient
• Avoid cartridges without a certificate of analysis and without a batch number
• Conspicuously viscous liquids that appear «cut» are a warning sign
• In case of shortness of breath, chest pain, or fever after consumption, seek immediate medical evaluation

Relevance for Swiss consumers

In Switzerland, liquids are subject to mandatory declaration under the Tobacco Products Act and food legislation; vitamin E acetate does not occur in regularly distributed products. The risk therefore shifts entirely to informally sourced cartridges — precisely where neither an ingredient list nor a laboratory report exists. Practical protection is therefore simple: only use declared products with a verifiable batch number.

In Switzerland, the following applies: cannabis products with less than 1 % total THC (THC + THCA × 0.877) are not narcotics and are freely available. Liquids and vaporizers also fall under the Tobacco Products Act (TabPG) — sales to minors under 18 are prohibited, and advertising is restricted. The analyzed value of the final product is always decisive, not the information on the packaging.

Pathophysiological mechanisms of lung injury

When vitamin E acetate is heated and subsequently inhaled, the oily substance penetrates deep into the air sacs, the so-called alveoli. Since this additive is a lipid, the human lung is not designed to absorb it in a gaseous state. The oil condenses on the moist tissue of the airways and mixes with the surfactant film located there. This paper-thin liquid film normally ensures that the alveoli do not collapse during exhalation. The oily deposit systematically destroys this protective layer, leading to severe functional impairment.

The immune system responds to these foreign bodies with a severe inflammatory reaction in order to clear the trapped oil. So-called macrophages migrate into the affected tissue and ingest the lipid droplets, transforming them into characteristic foam cells. This process leads to exogenous lipoid pneumonia, a specific form of pneumonia triggered not by pathogens, but by foreign substances. The progressive inflammation causes lasting damage to the lung tissue, hinders vital gas exchange, and can, in the worst-case scenario, lead to acute respiratory failure requiring intensive care treatment.

• Destruction of the vital surfactant film in the alveoli
• Accumulation of lipid-laden macrophages in the lung tissue
• Triggering of severe chemical inflammation without infectious pathogens
• Massive obstruction of oxygen transport into the bloodstream

Technical differentiation of vaporization methods

For risk assessment, a precise technical differentiation between the various vaporization devices on the market is essential. Conventional e-cigarettes designed for nicotine consumption use water-soluble carrier substances exclusively, such as propylene glycol and vegetable glycerin. These carriers do not require oily diluents, which is why there is no systemic risk of lipid-induced lung injury with regular e-liquids. Historically, EVALI cases occurred almost exclusively in connection with illicit THC cartridges, where criminal actors cut the viscous cannabinoid distillate with cheap, oily vitamin E acetate.

In contrast to liquid-based systems, so-called dry herb vaporizers operate on a completely different principle. In these devices, dried cannabis flowers or herbal resins are gently heated in a heating chamber without the involvement of liquid carriers or chemical additives. Since dry herb vaping involves no inhalation of synthetic formulations, solvents, or diluents, this method is physically completely free from the risk of EVALI. The botanical vaporization of natural flowers thus represents the cleanest form of inhalative consumption, provided the starting material is free of pesticides and mould.

• Nicotine e-liquids are based on water-soluble substances without oil additives
• EVALI risk primarily affects oily carriers in illegal THC cartridges
• Dry herb vaporizers heat pure flowers completely without chemical additives
• No risk of lipid pneumonia with pure dry herb vaping

Swiss control mechanisms and pilot projects

In Switzerland, a close-knit network of legal requirements ensures that consumers are protected from dangerous cutting agents. Since August 2022, medical cannabis has been directly accessible via medical prescription without an exceptional permit from the Federal Office of Public Health. These medical products are subject to the strictest pharmaceutical quality controls and are monitored by Swissmedic. The products distributed within the framework of state-approved pilot trials such as Züri Can or Weed Care in Basel are also seamlessly analysed in laboratories, completely ruling out the use of harmful diluents such as vitamin E acetate in the legal segment.

For the over-the-counter market of cannabis products with a total THC content of less than one percent, the provisions of the Food Act and the Tobacco Products Act apply. The Federal Food Safety and Veterinary Office as well as the cantonal laboratories regularly conduct random sampling to verify the marketability and declaration requirements of CBD liquids on the market. Since the addition of health-hazardous substances to consumer goods is strictly prohibited in Switzerland, the real risk of contaminated cartridges is almost exclusively limited to the illegal black market, which evades all state control.

• Pharmaceutical supervision of medical cannabis by Swissmedic since August 2022
• Seamless laboratory analyses in state-approved pilot trials
• Regular controls of the CBD market by cantonal laboratories
• Statutory ban on harmful cutting agents in the Tobacco Products Act

Recognising symptoms and correct behaviour in suspected cases

Early detection of onset lung damage is of crucial importance for the subsequent healing process. Since the symptoms of EVALI initially resemble a common cold or flu, they are often taken seriously too late by those affected. Typical warning signs include progressive shortness of breath, a persistent dry cough, sharp chest pain, as well as unexplained fever and fatigue. Gastrointestinal complaints such as nausea, vomiting, or abdominal pain are also common, indicating systemic stress on the body and occurring in temporal connection with the use of vaporisers.

If such symptoms occur after consuming liquid cannabis products, especially from unclear sources, medical assistance must be sought immediately. In Switzerland, the emergency number 145 of Tox Info Suisse is available to those affected and their relatives around the clock for free advice in cases of suspected poisoning or product intolerance. For the treating physicians, it is extremely important that users are completely transparent regarding the substances used. If possible, the cartridges or liquids used should be kept to enable a toxicological laboratory analysis.

• Watch for symptoms such as shortness of breath, coughing, chest pain, and fever
• Immediate contact with Tox Info Suisse via the emergency number 145
• Securing the suspected vape product for medical analysis
• Open communication with medical staff regarding consumption habits

FAQ